CONSULTING AGREEMENTConsulting Agreement • February 23rd, 2023 • Jounce Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledFebruary 23rd, 2023 Company Industry JurisdictionTHIS CONSULTING AGREEMENT (“Agreement”) is entered into as of February 22, 2023 and shall be effective at the close of business on the day that the Consultant’s employment with Jounce as a full-time, at-will employee terminates (such date, the “Effective Date”), by and between Richard Murray, Ph.D., an individual residing at [***] (hereinafter “Consultant”) and Jounce Therapeutics, Inc., a Delaware corporation, with its office located at 780 Memorial Drive, Cambridge, MA 02139 (hereinafter “Jounce”).
CONSULTING AGREEMENTConsulting Agreement • February 23rd, 2023 • Jounce Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledFebruary 23rd, 2023 Company Industry JurisdictionTHIS CONSULTING AGREEMENT (“Agreement”) is entered into as of February 22, 2023 and shall be effective at the close of business on the day that the Consultant’s employment with Jounce as a full-time, at-will employee terminates (such date, the “Effective Date”), by and between Hugh Cole, an individual residing at [***] (hereinafter “Consultant”) and Jounce Therapeutics, Inc., a Delaware corporation, with its office located at 780 Memorial Drive, Cambridge, MA 02139 (hereinafter “Jounce”).
CONSULTING AGREEMENTConsulting Agreement • February 23rd, 2023 • Jounce Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledFebruary 23rd, 2023 Company Industry JurisdictionTHIS CONSULTING AGREEMENT (“Agreement”) is entered into as of February 22, 2023 and shall be effective at the close of business on the day that the Consultant’s employment with Jounce as a full-time, at-will employee terminates (such date, the “Effective Date”), by and between Elizabeth Trehu, M.D., an individual with an address of [***] (hereinafter “Consultant”) and Jounce Therapeutics, Inc., a Delaware corporation, with its office located at 780 Memorial Drive, Cambridge, MA 02139 (hereinafter “Jounce”).